233 related articles for article (PubMed ID: 31704274)
1. Disease-modifying strategies in primary tauopathies.
Rösler TW; Costa M; Höglinger GU
Neuropharmacology; 2020 May; 167():107842. PubMed ID: 31704274
[TBL] [Abstract][Full Text] [Related]
2. A walk through tau therapeutic strategies.
Jadhav S; Avila J; Schöll M; Kovacs GG; Kövari E; Skrabana R; Evans LD; Kontsekova E; Malawska B; de Silva R; Buee L; Zilka N
Acta Neuropathol Commun; 2019 Feb; 7(1):22. PubMed ID: 30767766
[TBL] [Abstract][Full Text] [Related]
3. Tauopathies as clinicopathological entities.
Irwin DJ
Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1(0 1):S29-33. PubMed ID: 26382841
[TBL] [Abstract][Full Text] [Related]
4. An Overview on the Clinical Development of Tau-Based Therapeutics.
Medina M
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29641484
[TBL] [Abstract][Full Text] [Related]
5. Tau phosphorylation and aggregation as a therapeutic target in tauopathies.
Badiola N; Suárez-Calvet M; Lleó A
CNS Neurol Disord Drug Targets; 2010 Dec; 9(6):727-40. PubMed ID: 20942789
[TBL] [Abstract][Full Text] [Related]
6. Tau Spreading Mechanisms; Implications for Dysfunctional Tauopathies.
Fuster-Matanzo A; Hernández F; Ávila J
Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495325
[TBL] [Abstract][Full Text] [Related]
7. Brain microRNAs dysregulation: Implication for missplicing and abnormal post-translational modifications of tau protein in Alzheimer's disease and related tauopathies.
Bazrgar M; Khodabakhsh P; Mohagheghi F; Prudencio M; Ahmadiani A
Pharmacol Res; 2020 May; 155():104729. PubMed ID: 32126270
[TBL] [Abstract][Full Text] [Related]
8. Current Understanding of Neurodegenerative Diseases Associated With the Protein Tau.
Josephs KA
Mayo Clin Proc; 2017 Aug; 92(8):1291-1303. PubMed ID: 28778262
[TBL] [Abstract][Full Text] [Related]
9. Frontotemporal dementia with tau pathology.
Gasparini L; Terni B; Spillantini MG
Neurodegener Dis; 2007; 4(2-3):236-53. PubMed ID: 17596718
[TBL] [Abstract][Full Text] [Related]
10. Differential induction and spread of tau pathology in young PS19 tau transgenic mice following intracerebral injections of pathological tau from Alzheimer's disease or corticobasal degeneration brains.
Boluda S; Iba M; Zhang B; Raible KM; Lee VM; Trojanowski JQ
Acta Neuropathol; 2015 Feb; 129(2):221-37. PubMed ID: 25534024
[TBL] [Abstract][Full Text] [Related]
11. Intercellular transfer of tau aggregates and spreading of tau pathology: Implications for therapeutic strategies.
Clavaguera F; Grueninger F; Tolnay M
Neuropharmacology; 2014 Jan; 76 Pt A():9-15. PubMed ID: 24050961
[TBL] [Abstract][Full Text] [Related]
12. Posttranslational modifications of tau--role in human tauopathies and modeling in transgenic animals.
Chen F; David D; Ferrari A; Götz J
Curr Drug Targets; 2004 Aug; 5(6):503-15. PubMed ID: 15270197
[TBL] [Abstract][Full Text] [Related]
13. Altered Proteostasis in Neurodegenerative Tauopathies.
Papanikolopoulou K; Skoulakis EMC
Adv Exp Med Biol; 2020; 1233():177-194. PubMed ID: 32274757
[TBL] [Abstract][Full Text] [Related]
14. Analysis of tauopathies with transgenic mice.
Hutton M; Lewis J; Dickson D; Yen SH; McGowan E
Trends Mol Med; 2001 Oct; 7(10):467-70. PubMed ID: 11597522
[TBL] [Abstract][Full Text] [Related]
15. RNA and protein-dependent mechanisms in tauopathies: consequences for therapeutic strategies.
Gallo JM; Noble W; Martin TR
Cell Mol Life Sci; 2007 Jul; 64(13):1701-14. PubMed ID: 17453144
[TBL] [Abstract][Full Text] [Related]
16. Tauopathies.
Hernández F; Avila J
Cell Mol Life Sci; 2007 Sep; 64(17):2219-33. PubMed ID: 17604998
[TBL] [Abstract][Full Text] [Related]
17. Tau Abnormalities and the Potential Therapy in Alzheimer's Disease.
Almansoub HAMM; Tang H; Wu Y; Wang DQ; Mahaman YAR; Wei N; Almansob YAM; He W; Liu D
J Alzheimers Dis; 2019; 67(1):13-33. PubMed ID: 30507581
[TBL] [Abstract][Full Text] [Related]
18. Tauopathies: Deciphering Disease Mechanisms to Develop Effective Therapies.
Silva MC; Haggarty SJ
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255694
[TBL] [Abstract][Full Text] [Related]
19. Tau and tauopathies.
Lee G; Leugers CJ
Prog Mol Biol Transl Sci; 2012; 107():263-93. PubMed ID: 22482453
[TBL] [Abstract][Full Text] [Related]
20. Four-repeat tauopathies.
Rösler TW; Tayaranian Marvian A; Brendel M; Nykänen NP; Höllerhage M; Schwarz SC; Hopfner F; Koeglsperger T; Respondek G; Schweyer K; Levin J; Villemagne VL; Barthel H; Sabri O; Müller U; Meissner WG; Kovacs GG; Höglinger GU
Prog Neurobiol; 2019 Sep; 180():101644. PubMed ID: 31238088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
